We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effectiveness of the Original Monovalent Coronavirus Disease 2019 Vaccines in Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Adults With Disabilities: VISION Network, June 2021-September 2022.
- Authors
Patel, Palak; Schrader, Kristin E; Rice, Catherine E; Rowley, Elizabeth; Cree, Robyn A; DeSilva, Malini B; Embi, Peter J; Gaglani, Manjusha; Grannis, Shaun J; Ong, Toan C; Stenehjem, Edward; Naleway, Allison L; Ball, Sarah; Natarajan, Karthik; Klein, Nicola P; Adams, Katherine; Kharbanda, Anupam; Ray, Caitlin; Link-Gelles, Ruth; Tenforde, Mark W
- Abstract
Adults with disabilities are at increased risk for severe coronavirus disease 2019 (COVID-19). Using data across 9 states during Delta- and Omicron-predominant periods (June 2021–September 2022), we evaluated the effectiveness of the original monovalent COVID-19 messenger RNA vaccines among 521 206 emergency department/urgent care encounters (11 471 [2%] in patients with a documented disability) and 139 548 hospitalizations (16 569 [12%] in patients with a disability) for laboratory-confirmed COVID-19 illness in adults (aged ≥18 years). Across variant periods and for the primary series or booster doses, vaccine effectiveness was similar in those with and those without a disability. These findings highlight the importance of adults with disabilities staying up to date with COVID-19 vaccinations.
- Subjects
COVID-19; OUTPATIENT medical care; HOSPITAL emergency services; DISABILITIES; VACCINE effectiveness; PEOPLE with disabilities
- Publication
Open Forum Infectious Diseases, 2023, Vol 10, Issue 11, p1
- ISSN
2328-8957
- Publication type
Article
- DOI
10.1093/ofid/ofad474